A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral anti

Guo, LX; Chen, L; Chang, BC; Yang, LY; Liu, Y; Feng, B

Guo, LX (reprint author), Beijing Hosp, Dept Endocrinol, Natl Ctr Gerontol, 1 Dahua Rd, Beijing 100730, Peoples R China.

DIABETES OBESITY & METABOLISM, 2018; 20 (12): 2740

Abstract

Aim Materials and methods To confirm non-inferiority of biphasic insulin aspart 30 (BIAsp 30) plus metformin to BIAsp 30 in lowering glycated haemoglo......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索